$1.4MSeed, 11 November 2025
Builds a digital platform for allergy-like symptoms and expands in Lithuania and Poland.
- Amount
- $1.4M
- Stage
- Seed
- Announced
- 11 November 2025
- Lead
- Iron Wolf Capital
- Other investors
- Coinvest Capital, NGL Ventures, Business angels
- Use of funds
- Builds a digital platform for allergy-like symptoms and expands in Lithuania and Poland.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Lithuanian Self.co secures funding to expand accessible allergy diagnostics in Europe bebeez.eu
Lithuanian Self.co secures funding to expand accessible allergy diagnostics in Europe arcticstartup.com